GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Inventories, Finished Goods

AngioLab (XKRX:251280) Inventories, Finished Goods : ₩23.3 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Inventories, Finished Goods?

AngioLab's quarterly finished goods declined from Dec. 2021 (₩17.2 Mil) to Dec. 2022 (₩12.5 Mil) but then increased from Dec. 2022 (₩12.5 Mil) to Dec. 2023 (₩23.3 Mil).

AngioLab's annual finished goods declined from Dec. 2021 (₩17.2 Mil) to Dec. 2022 (₩12.5 Mil) but then increased from Dec. 2022 (₩12.5 Mil) to Dec. 2023 (₩23.3 Mil).

AngioLab Inventories, Finished Goods Historical Data

The historical data trend for AngioLab's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Inventories, Finished Goods Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial 6.48 7.56 17.17 12.48 23.26

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods Get a 7-Day Free Trial 6.48 7.56 17.17 12.48 23.26

AngioLab Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

AngioLab (XKRX:251280) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Inventories, Finished Goods
Comparable Companies
XKRX:072520 XKRX:446440 XKRX:215380 XKRX:322970 XKRX:283100 XKRX:950220 XKRX:343090 XKRX:179530 XKRX:388610 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
Website
http://www.angiolab.co.kr
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines